Mycotoxins and Celiac Disease: The Shared Battleground in Your Small Intestine

Celiac disease and mold illness — also called Chronic Inflammatory Response Syndrome (CIRS) — seem like entirely separate conditions. One is an autoimmune reaction to the gluten protein found in wheat, barley, and rye. The other is a whole-body inflammatory response triggered by biotoxins released by mold and other organisms in water-damaged buildings. Yet clinicians treating both conditions have noticed something striking: patients who improve dramatically on a gluten-free diet but never fully heal, patients with all the hallmarks of celiac disease who test negative for the classic antibodies, and celiac patients who do everything right and still suffer intestinal inflammation year after year.

The missing variable in many of these cases is mycotoxin exposure. A growing body of research demonstrates that mycotoxins — toxic secondary metabolites produced by mold species including Fusarium, Aspergillus, and Penicillium — attack the exact same anatomical target as gliadin peptides: the small intestinal epithelium. Specifically, the tight junction proteins that control what crosses the gut barrier. When that barrier fails, both conditions worsen, both become harder to treat, and both generate cascading systemic inflammation.

This guide explains the biological mechanisms linking mold, mycotoxins, and celiac disease; why many celiac patients living in moldy homes cannot fully heal; what testing can distinguish these overlapping conditions; and what you can do to address both the food and environmental sources of intestinal injury.

Deoxynivalenol (DON/Vomitoxin): The Grain Mycotoxin That Mimics Celiac Pathology

Deoxynivalenol, commonly called DON or vomitoxin, is produced primarily by Fusarium graminearum and Fusarium culmorum — two fungal species that infect wheat, barley, oats, corn, and rye during wet growing seasons. DON is not destroyed by cooking, baking, or standard food processing. It is heat-stable up to approximately 350°C, meaning that a loaf of bread made from DON-contaminated flour delivers a nearly identical DON dose as the raw grain.

DON is the most extensively studied mycotoxin for gastrointestinal effects, and the mechanisms it deploys against the intestinal epithelium are precisely those that define celiac pathology:

For a celiac patient, the consequences are severe. Even on a strict gluten-free diet, DON exposure from contaminated "gluten-free" grains can maintain a state of intestinal hyperpermeability. If any trace of gluten enters the body — through cross-contamination, shared cooking surfaces, or hidden gluten in processed foods — those gliadin peptides now have an open highway through the leaky epithelium to trigger the immune cascade. DON essentially keeps the door open that celiac disease requires to be shut.

The Fusarium-Grain-DON Connection in the Food Supply

Understanding how DON reaches a celiac patient's plate — even when they are eating "gluten-free" — requires understanding the food supply chain for the affected grains:

• Wheat, barley, and rye: These are the classic celiac-triggering grains and they are also the primary hosts for Fusarium species. Contamination rates in commercial wheat samples range from 30–80% in wet growing years.
• Oats: Oats are biologically gluten-free, and many celiac patients are told they can consume certified gluten-free oats safely. However, oats are also susceptible to Fusarium contamination. A Canadian study found DON in 73% of commercial oat samples. The certification process screens for gluten cross-contamination but does not screen for mycotoxins.
• Corn and rice: These grains are used extensively in gluten-free product formulations as wheat substitutes. Both are susceptible to Fusarium and aflatoxin contamination. Corn-based gluten-free products have been found to contain DON and fumonisins at levels exceeding those in conventional wheat products in some surveys.
• Buckwheat, amaranth, and quinoa: These "ancient grain" alternatives have lower Fusarium susceptibility but are not immune, particularly when improperly stored after harvest.

Zearalenone: A Second Fusarium Mycotoxin Affecting Gut Permeability

Deoxynivalenol is frequently accompanied in Fusarium-contaminated grain by zearalenone (ZEN), an estrogenic mycotoxin. Zearalenone's intestinal effects are distinct from DON but compound the damage:

ZEN binds to estrogen receptors (ERα and ERβ) in intestinal epithelial cells. These receptors are expressed throughout the small intestine — the precise zone damaged in celiac disease. Activation of intestinal estrogen receptors by ZEN alters epithelial barrier function through a different mechanistic pathway than DON (estrogenic signaling rather than ribotoxic stress), but the net result is the same: reduced tight junction protein expression and increased paracellular permeability.

ZEN also modulates immune function in the gut-associated lymphoid tissue (GALT), shifting the cytokine environment in ways that can amplify Th1 and Th17 responses — the dominant immune phenotypes in active celiac disease. Co-exposure to DON and ZEN (which is the rule, not the exception, in contaminated grain) produces additive or synergistic gut permeability effects compared to either toxin alone.

Aflatoxin and Villous Atrophy: A Celiac Look-Alike

Aflatoxin B1 (AFB1), produced by Aspergillus flavus and Aspergillus parasiticus and found primarily in corn, peanuts, tree nuts, and dried figs, generates intestinal pathology in animal models that is pathologically indistinguishable from celiac disease. AFB1 causes:

• Villous blunting and fusion of intestinal villi, reducing absorptive surface area
• Crypt hyperplasia — the same compensatory response seen in celiac disease as the intestine attempts to replace damaged villi
• Intraepithelial lymphocyte (IEL) infiltration — the histological hallmark of celiac disease used for Marsh grading on biopsy
• Brush border enzyme deficiency including reduced disaccharidase activity

This means that a patient consuming significant amounts of aflatoxin-contaminated food could present with a celiac-like biopsy without having the genetic predisposition (HLA-DQ2/DQ8) or the immunological mechanism. Conversely, a true celiac patient with concurrent aflatoxin exposure will show more severe villous damage than gluten alone would produce.

Indoor Mold and Gut Permeability: The Environmental Exposure Route

Celiac patients and gastroenterologists typically focus on dietary sources of mycotoxins — contaminated grain and food products. The indoor mold route is far less discussed but equally important. Patients living in water-damaged buildings are exposed to mycotoxins through multiple routes simultaneously:

When a celiac patient lives in a moldy home, all four exposure routes operate simultaneously. The resulting systemic mycotoxin load — even from indoor mold species that don't produce DON — generates whole-body intestinal permeability. Stachybotrys chartarum (black mold), common in water-damaged buildings, produces trichothecene mycotoxins (satratoxins, roridin, verrucarin) that activate identical MAP kinase / NFkB inflammatory cascades as DON. Aspergillus species common indoors produce gliotoxin and other immunosuppressive mycotoxins that impair the mucosal immune repair processes the celiac intestine depends on to heal.

See our guide to mold and systemic health effects and black mold symptoms for more on how indoor mold affects the body beyond the respiratory system.

The Celiac–CIRS Overlap: Shared Biology, Overlapping Patients

Chronic Inflammatory Response Syndrome (CIRS), the condition formally described by Dr. Ritchie Shoemaker resulting from mold and biotoxin exposure in water-damaged buildings, shares a remarkable degree of biological overlap with celiac disease:

Perhaps most clinically important: a substantial subset of CIRS patients improve significantly on a gluten-free diet without testing positive for celiac antibodies or HLA-DQ2/DQ8. These patients likely have non-celiac gluten sensitivity (NCGS) — a condition where the epithelial barrier damage from mycotoxins makes the intestine reactive to gliadin peptides through the innate immune system rather than the adaptive immune HLA-restricted pathway that defines classical celiac disease.

Read our related guides on mold and autoimmune disease and mold's effects on the immune system for the broader picture of how biotoxin exposure drives inflammatory conditions.

Why Celiac Patients in Moldy Homes Fail to Heal

Intestinal healing in celiac disease on a gluten-free diet is a slow process under the best circumstances. Villous atrophy measured on biopsy normalizes in 60–80% of adults after 2 years of strict dietary adherence. For 20–40% of celiac patients — classified as having "non-responsive celiac disease" — the intestinal mucosa never fully recovers despite apparent dietary compliance. Mycotoxin exposure is an underrecognized explanation for a significant fraction of these refractory cases.

The healing mechanisms that DON specifically impairs include:

• Epithelial cell proliferation: DON activates apoptotic pathways in intestinal epithelial cells (IECs), reducing crypt cell proliferation and slowing villous regeneration. The rate of new villous enterocyte production is the key determinant of mucosal recovery speed.
• Tight junction reassembly: Once tight junctions have been disrupted, re-establishing them requires coordinated synthesis and membrane trafficking of claudin, occludin, and ZO-1 proteins. DON suppresses this process, keeping the paracellular pathway open.
• Regulatory T-cell function: Adequate Treg function is required to dampen the anti-gliadin immune response as the gut heals. DON (and separately, mycotoxins from indoor black mold) impair Treg differentiation, perpetuating immune activation.
• Mucosal IgA production: Secretory IgA is the gut's first-line defense against luminal antigens. Many CIRS patients have depleted secretory IgA, which both increases susceptibility to gluten-related immune activation and impairs clearance of Fusarium-derived antigens in the gut.

The practical implication is sobering: a celiac patient living in a water-damaged home and strictly following a gluten-free diet may be losing ground to mycotoxin-mediated gut injury faster than the gluten-free diet is allowing the intestine to heal. Addressing the environmental mold exposure — not just dietary compliance — is essential for this patient to recover.

Mycotoxin Gut Effects: A Comparative Overview

Testing: Diagnosing the Mycotoxin–Celiac Intersection

When a celiac patient is not healing as expected, or when a patient with gut symptoms tests negative for celiac antibodies but has features of both conditions, a systematic evaluation should include:

Standard Celiac Panel

• Anti-tissue transglutaminase IgA (anti-tTG IgA): The most sensitive single test for celiac disease (95–98% sensitivity). Requires normal total serum IgA for valid interpretation — IgA deficiency (2–3% prevalence, 10× higher in celiac patients) will produce false-negative results.
• Anti-deamidated gliadin peptide IgG (anti-DGP IgG): The preferred test in IgA-deficient patients; also useful in early celiac disease before full antibody titers develop.
• Endomysial antibody IgA (EMA IgA): High specificity (near 100%) but lower sensitivity; useful as a confirmatory test. Requires experienced lab for accurate interpretation.
• Total serum IgA: Must be measured simultaneously with anti-tTG IgA to detect IgA deficiency. Note: chronic mycotoxin exposure can deplete secretory IgA, potentially producing false-negative celiac antibody results.

Mycotoxin Testing

• Urinary mycotoxins (Great Plains Laboratory / Vibrant Wellness): Measures urinary excretion of common mycotoxins including DON, ochratoxin A, aflatoxins, trichothecenes, and zearalenone. A positive panel in a celiac patient with ongoing symptoms is strong evidence for dietary or environmental mycotoxin burden.
• ERMI/HERTSMI-2 (home environmental testing): Environmental Relative Moldiness Index from dust sampling at home quantifies the mold species burden. Elevated Stachybotrys, Aspergillus, and Chaetomium scores indicate a water-damaged indoor environment contributing to toxin exposure.

Intestinal Permeability Assessment

• Lactulose/mannitol ratio (urine): The gold-standard functional measure of paracellular permeability. A high ratio indicates leaky gut irrespective of cause — elevated in both active celiac and DON-exposed individuals.
• Serum zonulin: Elevated in conditions of active tight junction disruption. Persistently elevated zonulin in a "controlled" celiac patient suggests an ongoing source of permeability beyond dietary gluten — consistent with mycotoxin exposure.
• Serum lipopolysaccharide (LPS) binding protein: Elevated LPS-BP indicates bacterial translocation through a leaky gut — a downstream consequence of both celiac disease and mycotoxin-mediated permeability.

Learn more about the mold testing process in our guide to mold testing methods and our mold inspection checklist.

Environmental Controls: Addressing the Source

The highest-leverage intervention for a celiac patient burdened by mycotoxins is eliminating the source of exposure. This requires addressing both the indoor environment and the food supply:

Home Environment

Priority mold remediation should be considered for any celiac patient who is not responding to dietary management as expected. Key action items include:

• ERMI or HERTSMI-2 home testing to establish mold burden before remediation
• Professional remediation of identified sources — not just surface cleaning but addressing the moisture source and removing contaminated porous materials
• HEPA air filtration (MERV-13 or true HEPA) in sleeping and living areas post-remediation to capture residual spores and hyphal fragments
• Dehumidification to maintain indoor relative humidity below 50% (55% maximum) — the threshold below which most mold species cannot actively grow

Our comprehensive guides on mold prevention and the DIY mold remediation process provide step-by-step action plans.

Grain and Food Storage

Mycotoxins accumulate in improperly stored grains and flours. Celiac patients relying heavily on alternative grain flours should:

• Purchase small quantities of grain flours (2 kg or less) and use within 4–6 weeks of opening
• Store all grain-based products in airtight glass or metal containers — not original paper bags or plastic bags
• Refrigerate or freeze nut flours and high-fat alternative flours (almond, coconut) which support mold growth at room temperature
• Discard any grain product showing any sign of visible mold immediately — and inspect for musty odor even without visible growth
• Avoid bulk-bin purchasing of alternative grains where cross-contamination and extended storage at uncontrolled humidity is standard

Dietary Approaches Beyond the Gluten-Free Diet

For celiac patients with suspected mycotoxin involvement, a standard gluten-free diet may be insufficient. A low-mycotoxin diet adds an additional layer of protection:

Conversely, certain dietary components actively degrade or reduce mycotoxin bioavailability:

• Fermented foods: Lactic acid bacteria (Lactobacillus species) in fermented foods produce organic acids and enzymes that degrade DON, ZEN, and aflatoxin B1. Sauerkraut, kimchi, and high-quality lactobacillus-fermented yogurt (if dairy is tolerated) can measurably reduce mycotoxin levels in the diet. Some strains of L. rhamnosus bind aflatoxin B1 in the gut.
• Activated charcoal (food-grade): Binds mycotoxins in the gastrointestinal tract; used clinically in aflatoxicosis treatment; some practitioners use it for dietary mycotoxin exposure in CIRS patients.
• Chlorophyll-rich vegetables: Chlorophyll and chlorophyllin have been shown in human trials to reduce aflatoxin-DNA adduct formation in the liver.

See our comprehensive guide to mold detox protocols for a full evidence-based dietary and supplement approach to reducing mycotoxin body burden.

Healing Support: Repairing the Gut Barrier

Once mycotoxin exposure is controlled — through both environmental remediation and dietary adjustment — targeted nutritional support can accelerate intestinal healing:

For a full overview of immune-supportive approaches, see our guides on mold and chronic fatigue and mold and anxiety, which cover how mycotoxin-related inflammation affects multiple body systems simultaneously.

Frequently Asked Questions

Related Resources